Approval · Notice of Compliance 37685 · 2026
RANVU: Notice of Compliance 37685
Issued June 10, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37685
- Date
- June 10, 2026
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
Medicinal ingredients
- RANIBIZUMAB 10 MG per ML